Stem Cell Therapy for Shoulder Pain: A Patient's Complete Guide

Shoulder pain has more potential causes than knee pain. The shoulder is the most mobile joint in the body and has overlapping anatomy that can refer pain from one structure to another, which makes the diagnostic workup matter more than it does for most other joints.

This guide walks through what regenerative medicine can and can't do for shoulder pain. The honest answer is that for the right indication, the toolkit works well; for the wrong indication, it doesn't. The work is figuring out which.

What's actually wrong with your shoulder?

The shoulder's complexity makes a quick survey worth doing. Pain in the shoulder can come from:

Rotator cuff pathology. The four rotator cuff muscles (supraspinatus, infraspinatus, teres minor, subscapularis) and their tendons can develop tendinopathy, partial tears, or full-thickness tears. The supraspinatus is by far the most commonly affected.

Labral injury. The glenoid labrum (the rim of cartilage around the shoulder socket) can tear, often from trauma or chronic overhead use. SLAP tears (superior labrum anterior-posterior) are a specific category common in throwing athletes.

Glenohumeral osteoarthritis. The shoulder joint itself can develop OA, though less commonly and usually later than the knee.

Acromioclavicular (AC) joint pathology. The joint where the clavicle meets the acromion can develop OA, instability, or separation injury.

Biceps tendon issues. The long head of the biceps tendon runs through the shoulder and can become inflamed (tenosynovitis), partially torn, or fully ruptured.

Adhesive capsulitis (frozen shoulder). A separate condition where the joint capsule itself becomes inflamed and contracted, producing severe stiffness.

Subacromial impingement and bursitis. Inflammation of the bursa under the acromion, often associated with rotator cuff tendinopathy.

Cervical referral. Pain from the neck can present as shoulder pain. Worth screening.

A typical 55-year-old with shoulder pain often has multiple things going on: rotator cuff tendinopathy with a small partial tear, biceps tendon inflammation, and mild AC joint OA. The right protocol addresses the dominant pain source.

The workup

For shoulder pain at Apex, the workup typically includes:

History. When the problem started (acute injury vs gradual onset), what makes it better or worse, what positions or activities provoke it, what you've tried, your goals. The pattern of pain often suggests the source: night pain in a specific position suggests rotator cuff; pain with overhead activity suggests impingement or labral; pain with cross-body movement suggests AC joint.

Targeted exam. Range of motion, both passive and active. Rotator cuff strength testing (empty can, full can, Hornblower, external rotation strength, lift-off). Impingement tests (Neer, Hawkins-Kennedy, painful arc). Labral provocation (O'Brien, anterior slide, Speed's). AC joint compression. Biceps tests. Cervical screen. Neurovascular exam.

Imaging review. Plain X-rays for bone alignment and AC joint. MRI is the workhorse for rotator cuff, labrum, glenohumeral cartilage, and soft tissue inflammation. MR arthrography (MRI with intra-articular contrast) is sometimes needed for clearer labral evaluation.

A good workup separates the common patterns within an hour. The most common diagnostic mistake we see in patients arriving for second opinions: the MRI was read for "obvious" findings (a partial tear, an osteophyte), and the actual primary pain source (biceps tenosynovitis, frozen shoulder, AC joint OA) was missed.

Rotator cuff tendinopathy

Tendinopathy without a tear is the most common shoulder problem in adults over 40. The tendon shows degenerative changes on MRI (intratendinous signal change, thickening) without a discrete tear.

Typical presentation. Gradual onset shoulder pain, often worse at night and with overhead activity. Sometimes radiates down the upper arm.

Conservative care first. PT focused on rotator cuff and scapular stabilizer strengthening. Activity modification. NSAIDs for short-term symptom control.

Regenerative approach. Leukocyte-rich PRP (LR-PRP) has the strongest evidence for chronic rotator cuff tendinopathy. Series of 1 to 2 injections separated by 4 to 6 weeks. Image-guided to the tendon itself, not just into the bursa.

Sometimes combined with shockwave. Particularly for chronic cases that have failed conservative care. Shockwave course before or after PRP can prime the tissue response.

Steroid injection caution. Subacromial corticosteroid is widely used for short-term relief but has a documented negative effect on tendon quality with repeated use. We typically prefer PRP for any patient considering more than one or two cortisone shots over the lifetime of their shoulder.

Expected response. 60 to 75 percent of patients show meaningful improvement at 12 to 16 weeks. Durability of 12+ months is typical in responders.

Rotator cuff partial-thickness tear

A tear that involves part but not the full thickness of the tendon. Classified by depth (under 50 percent vs over 50 percent) and location (articular-sided, bursal-sided, intratendinous).

Under 50 percent thickness tears. Often respond well to PRP, particularly LR-PRP, and to cellular therapy. The published evidence for PRP in this category is reasonable, with response rates and tear progression data favorable compared to natural history.

Over 50 percent thickness tears. Decision territory. Some patients respond to a regenerative approach; others progress to a full-thickness tear and need surgical repair. The surgical literature supports earlier intervention in some of these patients, particularly younger and more active ones.

Cellular therapy. Allogeneic MSC injection into the tendon and surrounding bursa has emerging evidence for partial-thickness cuff tears. Combined with PRP sometimes; standalone sometimes. Image guidance is essential.

Surgical alternatives. Arthroscopic rotator cuff repair, sometimes with biologic augmentation. The decision between regenerative and surgical approach depends on tear size, patient age, activity goals, and prior treatment response.

Expected response from regenerative care. 50 to 70 percent of partial-thickness tear patients show meaningful improvement; a subset have progression of the tear on follow-up imaging despite symptomatic improvement; some require eventual surgical repair.

Rotator cuff full-thickness tear

A complete tear through the tendon. Classified by size (small under 1cm, medium 1 to 3cm, large 3 to 5cm, massive over 5cm) and retraction.

Small and medium tears in older patients. Sometimes managed non-surgically with PT and (selectively) regenerative care. The published evidence for PRP and cellular therapy in this group is limited; most patients eventually consider surgical repair if function is meaningfully impaired.

Large and massive tears with retraction. Surgical territory. Regenerative therapy doesn't reconnect torn tendon to bone. In some cases, biologic augmentation at the time of surgical repair can support healing, particularly in older patients with poor native repair biology.

Massive tears with cuff-tear arthropathy. End-stage shoulder disease where the shoulder mechanics have collapsed. Reverse total shoulder arthroplasty is typically the right answer.

Irreparable tears. Some massive tears can't be repaired. Tendon transfer surgery, balloon spacer, or reverse arthroplasty are the options. Cellular therapy doesn't change the fundamental problem.

Glenohumeral osteoarthritis

The shoulder joint itself can develop OA, similar to the knee but less commonly. When it does, the same general grading logic applies.

Mild to moderate disease. Cellular therapy can produce meaningful symptomatic and functional improvement. Image-guided injection into the glenohumeral joint (using ultrasound; the shoulder joint is harder to access than the knee).

Severe disease. Total shoulder arthroplasty (TSA) or reverse total shoulder arthroplasty (RTSA, used when the rotator cuff is also deficient) is typically the right answer.

Combined OA plus cuff disease. Common pattern in older patients. Treatment depends on the relative severity of each and the patient's functional goals. Sometimes cellular therapy improves both; sometimes surgical intervention is the right call.

Expected response from cellular therapy in moderate glenohumeral OA. Smaller published evidence base than knee OA, but the available data and clinical experience are favorable. Response rates and durability appear roughly comparable to knee.

Labral pathology

The glenoid labrum is the cartilaginous rim around the shoulder socket. Labral tears can be:

Bankart lesions. Anterior labral tear, usually from a dislocation event. Often requires surgical repair in younger patients to prevent recurrent instability.

SLAP tears. Superior labrum anterior-posterior tears. Common in throwing athletes and in degenerative settings. Surgical management has been the traditional approach, but the literature increasingly supports a more conservative approach in many cases.

Posterior labral tears. Less common, sometimes related to specific repetitive loading patterns.

Degenerative labral fraying. Common in middle-aged and older adults, often incidentally found on MRI.

Regenerative approach to labral pathology. Limited but emerging. Cellular therapy and PRP can address some of the surrounding inflammation and irritation in chronic labral fraying or post-traumatic recovery. For frank Bankart lesions in patients with recurrent instability, surgical repair is typically the right answer.

Biologic augmentation in labral surgery. PRP, BMAC, or MSC use at the time of arthroscopic labral repair is increasingly common. The published evidence is growing but not yet definitive.

Biceps tendon pathology

The long head of the biceps tendon runs through the shoulder and can develop:

Tenosynovitis. Inflammation of the tendon sheath. Often responds to PRP or to corticosteroid injection into the sheath under ultrasound guidance.

Partial tear. Less common. May respond to regenerative care.

Full rupture (the "Popeye sign"). A complete tear, usually in older patients, leaving a characteristic bulge in the upper arm. Often managed non-surgically because the long head of biceps isn't essential for shoulder function; the short head and other elbow flexors compensate.

Pulley lesion or biceps subluxation. Mechanical instability of the biceps tendon as it courses through the bicipital groove. Sometimes surgical.

We see biceps pathology missed regularly in shoulders that have been treated for "rotator cuff tendinopathy" without specific attention to the biceps. The biceps deserves its own evaluation as part of any shoulder workup.

AC joint pathology

The acromioclavicular joint can develop OA, instability, or post-traumatic changes after a separation injury.

AC joint OA. Common in middle-aged and older patients, often presenting as pain at the top of the shoulder, worse with cross-body movement. Often responsive to ultrasound-guided corticosteroid or to PRP. Cellular therapy is rarely the first answer for isolated AC pathology because the joint is small and the disease often responds to lower-intensity intervention.

AC separation. Trauma-induced disruption of the AC and/or coracoclavicular ligaments. Graded I to VI. Lower grades (I-II) usually heal with conservative care; higher grades sometimes require surgical fixation.

Distal clavicle osteolysis. Specific pattern of bony resorption at the distal clavicle, often in weightlifters. Sometimes responsive to activity modification plus injection-based therapy.

Adhesive capsulitis (frozen shoulder)

A specific condition where the joint capsule itself becomes inflamed and contracted, producing severe loss of range of motion. Three phases: freezing (painful, gradual stiffness onset), frozen (severe stiffness, less pain), thawing (gradual return of motion). Total course often 12 to 24+ months.

Standard treatment. Aggressive PT plus intra-articular corticosteroid injection (often with hydrodilatation) plus time.

Regenerative role. Limited. Cellular therapy for adhesive capsulitis has not shown strong evidence. The disease appears to be primarily a capsule fibrosis problem rather than a cartilage or tendon problem, and the toolkit that works for cuff tendinopathy and OA doesn't translate well.

Surgical alternatives. Manipulation under anesthesia, arthroscopic capsular release for refractory cases.

We screen for adhesive capsulitis on every shoulder consultation. Patients who arrive thinking they need cellular therapy when the actual diagnosis is frozen shoulder leave with a different (and usually more effective) plan.

Subacromial impingement and bursitis

A separate but related entity to rotator cuff tendinopathy. The subacromial space narrows during overhead motion, pinching the bursa and cuff. Can be primary (anatomic, related to acromion shape) or secondary (functional, related to cuff weakness, scapular dyskinesis, or capsular tightness).

Standard treatment. PT focused on scapular and cuff mechanics, activity modification, sometimes ultrasound-guided subacromial corticosteroid.

Regenerative role. Subacromial PRP is sometimes used as an alternative to corticosteroid, particularly in patients who would benefit from avoiding the long-term effects of repeated steroid exposure.

Surgical alternatives. Subacromial decompression for refractory cases, though the published literature has been less favorable to this surgery in recent years.

How we structure protocols

A few common scenarios and how the protocol typically looks:

Rotator cuff tendinopathy without tear. LR-PRP injection, image-guided to the affected tendon and the subacromial bursa. Often combined with a structured PT program. Sometimes preceded by a shockwave course for chronic recalcitrant cases.

Partial-thickness cuff tear under 50 percent. PRP or cellular therapy, depending on patient profile and goals. Image-guided to the tear site and surrounding tissue. Activity modification and structured rehab.

Chronic biceps tenosynovitis. PRP injection into the biceps tendon sheath under ultrasound guidance.

Moderate glenohumeral OA. Cellular therapy with allogeneic MSCs and exosomes, image-guided intra-articular injection. Sometimes combined with a subacromial injection if cuff involvement is significant.

AC joint OA. Ultrasound-guided PRP or corticosteroid into the AC joint.

Combined pathology. Sequenced multi-site injections, often targeting the dominant pain source first and addressing secondary sources at follow-up.

What recovery looks like

For most shoulder regenerative procedures:

Day of procedure. 60 to 90 minutes total. Image-guided injection. Sometimes mild local anesthetic for patient comfort.

Days 1 to 5. Local soreness, occasionally pronounced. Acetaminophen, ice, sling for comfort if needed.

Week 1. Restricted overhead activity, no heavy lifting, no high-load exercise. Light cardio and lower-body work fine.

Weeks 2 to 4. Begin a structured PT program if not already underway. Progressive return to normal daily activity. Continued restriction on overhead loading and heavy lifting.

Weeks 4 to 8. Most patients begin to notice improvement. Progressive return to most activity.

Weeks 8 to 12. Continued improvement. Return to sport-specific or work-specific activity as tolerated.

Months 3 to 6. Peak response. Re-evaluation around 12 weeks with formal outcome measures.

When to think surgery

A few patterns where surgical consultation should be the next step rather than regenerative therapy:

Massive cuff tear with significant retraction. The structural problem is past what cells can plausibly address.

Severe glenohumeral OA. Replacement is the answer.

Recurrent shoulder instability with documented labral injury. Surgical stabilization.

Acute traumatic full-thickness cuff tear in a young, active patient. Earlier surgical repair often has better outcomes than waiting.

Frozen shoulder that has failed conservative care for 12+ months. Manipulation or arthroscopic release.

Significant biomechanical problems (severe scapular dyskinesis, AC instability with deformity) that won't respond to injection-based therapy.

If your case fits one of these patterns, we'll tell you and refer to a surgeon we trust.

Specific patient profiles

The 58-year-old golfer with chronic shoulder pain and a small partial-thickness supraspinatus tear. Typical PRP candidate with shockwave priming. Realistic goal: return to golf within 3 to 4 months, sustained improvement at 12 months.

The 72-year-old with massive cuff tear arthropathy. Reverse total shoulder arthroplasty conversation. Not a cellular therapy candidate.

The 45-year-old with persistent post-injury shoulder pain after a year of conservative care and PT. Workup carefully. Often a combination of cuff tendinopathy, biceps issues, and subacromial inflammation. Sequenced PRP protocol usually appropriate.

The 35-year-old throwing athlete with SLAP-pattern symptoms. Surgical consultation. Some SLAP tears respond to conservative and regenerative care; others need arthroscopic repair. Decision depends on imaging, exam, and goals.

The 65-year-old with moderate glenohumeral OA and intact rotator cuff. Cellular therapy candidate. Realistic 18 to 24 month improvement window.

The 55-year-old in the frozen shoulder pattern. Aggressive PT, intra-articular steroid with hydrodilatation, time. Not a cellular therapy case.

How to book

To request a consultation about your shoulder, request a consultation or call (972) 768-2328. We're at 2111 Kirkwood Blvd, Suite 110b, Southlake, TX 76092.

If you've been told by another clinic that you need cuff repair or shoulder replacement and want a second opinion, bring the imaging. We're happy to be one of the clinics you compare.

A short note from Dr. Abdullah

Shoulders are the joint where careful diagnostic work matters most. The same MRI can be read three different ways depending on who's looking and what they're looking for, and patients often arrive with a "rotator cuff" diagnosis when the actual pain generator is the biceps, the AC joint, or the capsule. The first hour of our shoulder consultation is mostly listening and looking; that's where the right protocol gets decided. Cellular therapy and PRP are excellent tools when the indication fits. When it doesn't, no amount of biologic enthusiasm makes them the right answer.